Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed director
Quarterly results
Director departure
|
|
ANGIOTECH PHARMACEUTICALS INC (ANPMF)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/16/2011 |
8-K
| Credit agreement amendment, Appointed a new director|
Docs:
|
"First Amendment to Notice of Articles of Angiotech Pharmaceuticals, Inc.",
"Second Amendment to Notice of Articles of Angiotech Pharmaceuticals, Inc.",
"Articles of Angiotech Pharmaceuticals, Inc",
"Indenture, by and among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for senior secured floating rate notes due 2013",
"Supplemental Indenture, by and among Angiotech Pharmaceuticals, Inc., certain of its subsidiaries party thereto and Deutsche Bank National Trust Company, as trustee, for senior floating rate notes due 2013",
"Credit Agreement, by and among Angiotech Pharmaceuticals, Inc., as Parent, the subsidiaries of Parent listed as borrowers on the signature pages thereto, as borrowers, the lenders signatory thereto, as lenders and Wells Fargo Capital Finance, LLC as arranger and administrative agent",
"Registration Rights Agreement, among Angiotech Pharmaceuticals, Inc. and the investors party thereto",
"Angiotech Pharmaceuticals, Inc. 2011 Stock Incentive Plan",
"Form of Restricted Share Unit Award Agreement (for Canadian participants)",
"Form of Restricted Stock Award Agreement (for U.S. Participants)" |
|
|
|